BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7893363)

  • 1. LQ-based model for biological radiotherapy planning.
    Koukourakis MI; Damilakis J
    Med Dosim; 1994; 19(4):269-77. PubMed ID: 7893363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The linear-quadratic transformation of dose-volume histograms in fractionated radiotherapy.
    Wheldon TE; Deehan C; Wheldon EG; Barrett A
    Radiother Oncol; 1998 Mar; 46(3):285-95. PubMed ID: 9572622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The radiobiology of hypofractionation.
    Nahum AE
    Clin Oncol (R Coll Radiol); 2015 May; 27(5):260-9. PubMed ID: 25797579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the radiobiological impact of anatomic modifications during radiation therapy for head and neck cancer: can we simply summate the dose?
    Orban de Xivry J; Castadot P; Janssens G; Lee JA; Geets X; Grégoire V; Macq B
    Radiother Oncol; 2010 Jul; 96(1):131-8. PubMed ID: 20542344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A feasibility study of spatiotemporally integrated radiotherapy using the LQ model.
    Kim M; Phillips MH
    Phys Med Biol; 2018 Dec; 63(24):245016. PubMed ID: 30523816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurements of characteristics of time pattern in dose delivery in step-and-shoot IMRT.
    Schäfer M; Münter M; Sterzing F; Häring P; Rhein B; Debus J
    Strahlenther Onkol; 2005 Sep; 181(9):587-94. PubMed ID: 16170486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiobiological evaluation of the radiation dose as used in high-precision radiotherapy: effect of prolonged delivery time and applicability of the linear-quadratic model.
    Shibamoto Y; Otsuka S; Iwata H; Sugie C; Ogino H; Tomita N
    J Radiat Res; 2012; 53(1):1-9. PubMed ID: 21997195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A radiobiological model for the relative biological effectiveness of high-dose-rate 252Cf brachytherapy.
    Rivard MJ; Melhus CS; Zinkin HD; Stapleford LJ; Evans KE; Wazer DE; Odlozilíková A
    Radiat Res; 2005 Sep; 164(3):319-23. PubMed ID: 16137205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The radiobiology of conventional radiotherapy and its application to radionuclide therapy.
    Dale R; Carabe-Fernandez A
    Cancer Biother Radiopharm; 2005 Feb; 20(1):47-51. PubMed ID: 15778580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implications of incomplete repair parameters for rat spinal cord: the feasibility of large doses per fraction in PDR and HDR brachytherapy.
    Pop LA; Millar WT; Visser AG; van der Kogel AJ
    Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):215-26. PubMed ID: 11516872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges in radiobiological modeling: can we decide between LQ and LQ-L models based on reviewed clinical NSCLC treatment outcome data?
    Santiago A; Barczyk S; Jelen U; Engenhart-Cabillic R; Wittig A
    Radiat Oncol; 2016 May; 11():67. PubMed ID: 27154064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of the LQ model to the interpretation of absorbed dose distribution in the daily practice of radiotherapy.
    Scalliet P; Cosset JM; Wambersie A
    Radiother Oncol; 1991 Nov; 22(3):180-9. PubMed ID: 1771259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The linear-quadratic model and most other common radiobiological models result in similar predictions of time-dose relationships.
    Brenner DJ; Hlatky LR; Hahnfeldt PJ; Huang Y; Sachs RK
    Radiat Res; 1998 Jul; 150(1):83-91. PubMed ID: 9650605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-fraction dose delivery timing during stereotactic radiotherapy can influence the radiobiological effect.
    Murphy MJ; Lin PS; Ozhasoglu C
    Med Phys; 2007 Feb; 34(2):481-4. PubMed ID: 17388164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extending the linear-quadratic model for large fraction doses pertinent to stereotactic radiotherapy.
    Guerrero M; Li XA
    Phys Med Biol; 2004 Oct; 49(20):4825-35. PubMed ID: 15566178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of setup uncertainties on the radiobiological advantage of fractionation in stereotaxic radiotherapy.
    Lo YC; Ling CC; Larson DA
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):1113-9. PubMed ID: 8600095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiobiological assessment of non-standard and novel radiotherapy treatments using the linear-quadratic model.
    Dale RG
    Med Biol Eng Comput; 1993 Jan; 31(1):53-7. PubMed ID: 8326764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A TCP-NTCP estimation module using DVHs and known radiobiological models and parameter sets.
    Warkentin B; Stavrev P; Stavreva N; Field C; Fallone BG
    J Appl Clin Med Phys; 2004; 5(1):50-63. PubMed ID: 15753933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric and radiobiological impact of dose fractionation on respiratory motion induced IMRT delivery errors: a volumetric dose measurement study.
    Duan J; Shen S; Fiveash JB; Popple RA; Brezovich IA
    Med Phys; 2006 May; 33(5):1380-7. PubMed ID: 16752574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of a large number of clinical studies for breast cancer radiotherapy: estimation of radiobiological parameters for treatment planning.
    Guerrero M; Li XA
    Phys Med Biol; 2003 Oct; 48(20):3307-26. PubMed ID: 14620060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.